Frequency and Self-reported Outcomes of Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder in the U.S. and Latin America Article

Aziz, H, Vidal-Martinez, G, Onyeka, OC et al. (2026). Frequency and Self-reported Outcomes of Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder in the U.S. and Latin America . 10.1016/j.rcp.2025.09.002

cited authors

  • Aziz, H; Vidal-Martinez, G; Onyeka, OC; Anderberg, JL; Vargas-Medrano, J; Sotelo, D; Kourtesi, D; Frederick, RM; Muñoz, JS; Berrones, D; Zavala Cruz, V; Thompson, P; Tonarelli, S; Wiese, AD; Crowley, JJ; Storch, EA; Adorno, VR; Agostini, V; Aguilar, WW; Aguirre, C; Alvarado-Quiroz, V; Ancalade, NE; Aponte, D; Espinosa, AAA; Arnold, PD; Ascencio-Chicana, EY; Atkinson, EG; Avery, J; Ayala, JN; Aziz, H; Aguirre, TLB; Barrera, CN; Contreras, JAB; Barry, K; Belanger, AN; Benitez, LM; Best, JR; Bigdeli, TB; Bommiasamy, H; Borda, T; Boyajian, L; Muñoz, DB; Browning, L; Burton, CL; Busto, C; Buxbaum, JD; Rivera, REC; Callahan, JL; Gomez, CAC; Canchari, E; Carrrera, MC; Chang, A; Chazelle, E; Cheng, JSC; Chire, JM; Muñoz, MC; Cicero, DC; Cifuentes-Espinoza, AP; Quiroz, PC; Colombo, GM; Comer, JS; Condori-Apaza, L; Cortina, J; Crosbie, J; Crowley, JJ; Cruz, VO; Cruz, IA; Cunning, A; Perez, GJD; Dailey, MM; Dang, BD; Dawson, A; del Río, D; Dev, A; Diaz, S; Fay, L; Fernandez, A; Figueroa, EG; Flecha, LM; Flores-Garcia, ÁM; Franklin, ME; Frederick, RM; Furr, JM; Gamarra, OM; Garay-Contreras, C; García-Bravo, N; García-Jaimes, C; Garrison, SR; Giusti-Rodriguez, P; Gonzalez, A; González, RA; Gonzalez-Barrios, P; Goodman, WK; Gorosito, JD; Grice, DE; Guintivano, J; Guttfreund, D; Halvorsen, MW

abstract

  • Introduction Obsessive compulsive disorder (OCD) affects about 1–2% of the global population, with roughly 30% of patients not responding to first-line treatments. Transcranial magnetic stimulation (TMS) has some support for treatment-resistant OCD but global use is unclear. Methods This study describes the frequency with which TMS was reported to be received among a large cohort of individuals who self-identified as Latino-Hispanic in Latin America and the United States. Among 3391 participants, 76 (2.2%) had completed TMS for OCD. Results Recipients who received TMS exhibited more severe current and lifetime OCD symptoms compared to non-recipients. On average, participants underwent 22.61 TMS sessions (SD = 20.96), and self-reported experiencing minimal to some improvement from TMS. The majority of TMS recipients were from Brazil ( n = 26), Mexico ( n = 17) and USA ( n = 16). Conclusions Findings suggest that TMS does not appear to be widely used in OCD treatment among the Latino-Hispanic population, particularly in Latin American countries. Further study of TMS efficacy and dissemination in underserved regions is warranted.

publication date

  • January 1, 2026

Digital Object Identifier (DOI)